Patent · US Expired

Synthesis of phenstatin and prodrugs thereof

US6943194B1 · kind B1 · utility

4Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 1999
Grant dateSep 13, 2005
Priority date
Expiry dateJan 9, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A newly discovered antineoplastic compound denominated “phenstatin” is herein described as are synthetic methods for producing phenstatin and the active prodrug thereof. Phenstatin was converted to the sodium phosphate prodrug (3d) by a dibenzylphosphite phosphorylation and subsequent hydrogenolysis sequence 3b→3c→3d. Phenstatin (3b) was found to be a potent inhibitor of tubulin polymerization and the binding of colchicine to tubulin comparable to combretastatin A-4 (1b).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.